<article xmlns="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://dtd.nlm.nih.gov/2.0/xsd/archivearticle http://dtd.nlm.nih.gov/2.0/xsd/archivearticle.xsd" article-type="review-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Curr Opin Microbiol</journal-id>
      <journal-title>Current Opinion in Microbiology</journal-title>
      <issn pub-type="ppub">1369-5274</issn>
      <issn pub-type="epub">1879-0364</issn>
      <publisher>
        <publisher-name>Current Biology</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">2697328</article-id>
      <article-id pub-id-type="pmid">19144561</article-id>
      <article-id pub-id-type="publisher-id">COMICR616</article-id>
      <article-id pub-id-type="doi">10.1016/j.mib.2008.11.006</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>The effector repertoire of enteropathogenic <italic>E. coli</italic>: ganging up on the host cell</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Dean</surname>
            <given-names>Paul</given-names>
          </name>
          <email>p.dean@ncl.ac.uk</email>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kenny</surname>
            <given-names>Brendan</given-names>
          </name>
          <email>brendan.kenny@ncl.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff>
        <addr-line>Institute for Cell and Molecular Biosciences, Medical School, Newcastle University, Catherine Cookson Building, Framlington Place, Newcastle upon Tyne NE2 4HH, UK</addr-line>
      </aff>
      <pub-date pub-type="ppub">
        <month>2</month>
        <year>2009</year>
      </pub-date>
      <volume>12</volume>
      <issue>1-3</issue>
      <fpage>101</fpage>
      <lpage>109</lpage>
      <history/>
      <permissions>
        <copyright-statement>© 2009 Elsevier Ltd.</copyright-statement>
        <copyright-year>2008</copyright-year>
        <copyright-holder>Elsevier Ltd</copyright-holder>
        <license>
          <p>This document may be redistributed and reused, subject to <ext-link ext-link-type="uri" xlink:href="http://www.elsevier.com/wps/find/authorsview.authors/supplementalterms1.0">certain conditions</ext-link>.</p>
        </license>
      </permissions>
      <abstract>
        <p>Diarrhoeal disease caused by enteropathogenic <italic>E. coli</italic> (EPEC) is dependent on a delivery system that injects numerous bacterial ‘effector’ proteins directly into host cells. The best-described EPEC effectors are encoded together on the locus of enterocyte effacement (LEE) pathogenicity island and display high levels of multifunctionality and cooperativity within the host cell. More recently, effectors encoded outside the LEE (non-LEE effectors) have been discovered and their functions are beginning to be uncovered. The recent completion of the EPEC genome sequence suggests its effector repertoire consists of at least 21 effector proteins. Here, we describe the genomic location of effectors and discuss recent advances made on effector cellular function as well as their role in the infection process.</p>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Introduction</title>
      <p>Enteropathogenic <italic>E. coli</italic> (EPEC) is a human pathogen of the small intestine that causes severe watery diarrhoea, particularly among infants in developing countries [<xref rid="bib1" ref-type="bibr">1</xref>]. EPEC is a member of a closely related family of pathogens that induce characteristic attaching and effacing (A/E) lesions on intestinal epithelial cells in humans (EPEC and EHEC — enterohaemorrhagic <italic>E. coli</italic>), ruminants (EHEC) and small animals including mice (<italic>Citrobacter rodentium</italic>) [<xref rid="bib2" ref-type="bibr">2</xref>]. Hallmarks of EPEC disease are loss (effacement) of absorptive microvilli, induction of actin-rich pedestals underneath adherent bacteria, rapid watery diarrhoea, inhibition of nutrient/water transporter function, mitochondrial dysfunction, a weak inflammatory response and tight junction (TJ) disruption (see [<xref rid="bib1 bib3" ref-type="bibr">1,3</xref>]). Upon initial contact with intestinal enterocytes, mediated in part by the bundle forming pilus (BFP), EPEC rapidly cause the effacement of microvilli and induce localised actin polymerisation that gives rise to a pedestal beneath the bacteria, to which the bacteria intimately attach. Mitochondrial dysfunction and disruption of nutrient transporters are also early events, whilst the disruption of TJ is only apparent later on during the infection process. EPEC is considered a non-invasive pathogen and relies upon on a type three secretion system (T3SS) to deliver effector proteins directly into host cells which subvert a myriad of host cellular functions, ultimately leading to disease [<xref rid="bib3" ref-type="bibr">3</xref>]. The first EPEC effectors to be discovered are all encoded on a large genomic pathogenicity island called the locus of enterocyte effacement (LEE), which also carries EPEC's only T3SS, with seven LEE effectors identified to date. More recently, effectors encoded outside the LEE region have been found in all A/E pathogens [<xref rid="bib4 bib5" ref-type="bibr">4,5</xref>] which utilise the LEE T3SS for delivery into host cells and recent functional studies on these ‘non-LEE’ effectors have started to ascribe cellular functions to these proteins. The completion of the genome sequence of the prototypical EPEC strain E2348/69 (herein termed EPEC; <ext-link xlink:href="http://www.sanger.ac.uk/Projects/Escherichia_Shigella" ext-link-type="uri">www.sanger.ac.uk/Projects/Escherichia_Shigella</ext-link>) has confirmed the presence (or absence) of many non-LEE effector genes [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>].</p>
      <p>EPEC also possess a type two secretion system (T2SS), although little is known about its role in virulence or its protein substrates [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>], and a type five secretion system (T5SS) which includes the enterotoxin EspC and other putative autotransporters [<xref rid="bib7 bib8" ref-type="bibr">7,8<sup>••</sup></xref>]. Interestingly, the entry of EspC into the host cells has been shown to be dependent on T3SS [<xref rid="bib8" ref-type="bibr">8<sup>••</sup></xref>] and it is likely that other autotransporters may also depend on the T3SS. In this review we will focus on the repertoire of type three secreted EPEC effector proteins and the important advances made on effector functions over the past few years. We redirect the reader to other reviews for information on other virulence factors and general mechanisms of EPEC pathogenesis [<xref rid="bib1 bib3 bib7" ref-type="bibr">1,3,7</xref>].</p>
    </sec>
    <sec>
      <title>EPEC effector nomenclature</title>
      <p>The naming of EPEC effectors has been based on three approaches and may be somewhat confusing to the lay reader. Traditionally, the term ‘Esp-’ was used to denote <italic>E</italic>PEC <italic>s</italic>ecreted <italic>p</italic>rotein and now includes the LEE effectors EspB/F/G/H. However, EspA and EspD, which have not been reported to possess effector activity, and the autotransporter EspC, also fall into this category, making effector designation a little ambiguous. A different approach was to name effectors to reflect their reported function, thus the LEE effectors Translocated Intimin receptor (Tir) and Mitochondrial-associated protein (Map) fall into this group. Finally, the term <italic>n</italic>on-<italic>L</italic>EE <italic>e</italic>ncoded (Nle-) was coined by Deng <italic>et al.</italic> following their discovery of several non-LEE effectors in <italic>Citrobacter</italic> [<xref rid="bib4" ref-type="bibr">4</xref>]. However, this designation has not been adopted for all non-LEE effectors — such as the non-LEE located EspG2/Orf3 [<xref rid="bib9" ref-type="bibr">9</xref>], EspI/NleA [<xref rid="bib10" ref-type="bibr">10</xref>], cycle inhibiting factor (Cif) [<xref rid="bib11" ref-type="bibr">11</xref>] and a set of recently discovered non-LEE effectors in EHEC, which have all been given the prefix ‘Esp-’ [<xref rid="bib5" ref-type="bibr">5</xref>], of which EspJ and EspL are encoded in EPEC (<xref rid="tbl1" ref-type="table">Table 1</xref>).</p>
    </sec>
    <sec>
      <title>The LEE effectors — highly interdependent and multifunctional</title>
      <p>Historically, the LEE effectors were the first to be identified in EPEC and to date a total of seven LEE-encoded proteins delivered into the host cell have been discovered, namely Tir, Map, EspF, EspG, EspZ (previously SepZ), EspH and EspB (which is also a translocator and essential for the delivery of effectors into the host cell) (see <xref rid="tbl1" ref-type="table">Table 1</xref> and [<xref rid="bib3" ref-type="bibr">3</xref>]). Also present on the LEE is the outer membrane protein Intimin which, whilst not delivered into host cells, causes numerous host cell responses directly through its bacterial-encoded receptor Tir or through various host cell receptors [<xref rid="bib1 bib3" ref-type="bibr">1,3</xref>]. All the LEE effectors, except EspZ [<xref rid="bib12" ref-type="bibr">12</xref>], have proven deleterious effects on the host cell (<xref rid="tbl1" ref-type="table">Table 1</xref> and see [<xref rid="bib3" ref-type="bibr">3</xref>]) and it is likely that EspZ has important effector functions as it is delivered early in the infection process and at similarly high levels as the essential virulence determinant, Tir [<xref rid="bib13" ref-type="bibr">13</xref>]. The importance of the LEE effectors in the disease process is unclear but animal infections using <italic>Citrobacter</italic> and EHEC (as EPEC lacks a suitable animal model) indicate that Tir is essential, linked to its role in bacterial attachment, whilst the other LEE effectors have a smaller but additive contribution to virulence [<xref rid="bib2 bib10 bib14 bib15" ref-type="bibr">2,10,14,15</xref>].</p>
      <p>The functions of the LEE effectors are highly varied and <xref rid="tbl1" ref-type="table">Table 1</xref> gives an up-to-date and comprehensive list of reported effector functions. An emerging theme for the LEE effectors, consistent with findings in other T3SS-pathogens, is their multiple and overlapping functions (termed functional redundancy) and their interdependence and cooperativity in subverting host cell activities (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig1" ref-type="fig">Figure 1</xref>). For example, Map and EspF synergise [<xref rid="bib16" ref-type="bibr">16</xref>] whilst EspG and EspG2 function redundantly [<xref rid="bib17" ref-type="bibr">17</xref>] in the disruption of epithelial TJ, with the Map/EspF TJ-disrupting activity proven <italic>in vivo</italic> [<xref rid="bib14 bib18" ref-type="bibr">14,18</xref>]. Tir is essential for actin-pedestal formation following binding to Intimin but is also involved in TJ disruption, independent and dependent of Intimin (Dean and Kenny, unpublished). Tir also downregulates Map-induced filopodia formation (see [<xref rid="bib3" ref-type="bibr">3</xref>]) and coordinates with EspF, Intimin and Map to cause microvilli effacement [<xref rid="bib19" ref-type="bibr">19<sup>•</sup></xref>]. Indeed, Knutton and colleagues have also reported overlapping roles for LEE effectors in microvilli effacement <italic>ex vivo</italic>, using human intestinal material [<xref rid="bib20" ref-type="bibr">20</xref>]. In addition, Map and EspF both target mitochondria to alter organelle shape and cause dysfunction — an activity that occurs <italic>in vivo</italic> and proven to be important in disease [<xref rid="bib14 bib15" ref-type="bibr">14,15</xref>]. Such effector cooperativity appears to be just the ‘tip of the iceberg’ as a systematic genetic study in which the LEE effectors were deleted in many different combinations eludes to an unprecedented level of functional cooperativity between effectors (Kenny <italic>et al.</italic>, unpublished). To this end, all the major reported hallmarks of EPEC disease can be attributed to the cooperative efforts of the LEE effectors (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p>
      <p>In addition to their cooperative nature, the LEE effectors are strikingly multifunctional (<xref rid="tbl1" ref-type="table">Table 1</xref>) binding a large number of eukaryotic proteins and targeting various host cell compartments (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig1" ref-type="fig">Figure 1</xref>). This is best exemplified by EspF which localises to multiple cellular compartments (including cytoplasm, mitochondria, apical and lateral membranes) and interacts with at least 12 reported host proteins, with its delivery linked to mitochondrial dysfunction, microvilli effacement, TJ disruption, apoptosis, epithelial transporter inhibition, anti-phagocytosis, membrane remodelling and actin-pedestal maturation [<xref rid="bib15 bib16 bib18 bib19 bib20 bib21 bib22 bib26 bib51 bib52 bib53" ref-type="bibr">15,16,18–22,26,51–53</xref>]. Like other LEE effectors, the modular construction of EspF facilitates its multifunctional behaviour (<xref rid="fig2" ref-type="fig">Figure 2</xref>), with specific motifs inducing distinct cellular responses, such as an N-terminal mitochondrial targeting sequence (MTS) linked to mitochondria dysfunction and apoptosis [<xref rid="bib15 bib21" ref-type="bibr">15,21</xref>], whilst proline-rich repeats, that include src homology 3 (SH3)-binding domains, recruit sorting nexin 9 (SNX9) causing membrane remodelling ([<xref rid="bib22" ref-type="bibr">22</xref>]; <xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig2" ref-type="fig">Figure 2</xref>). EspF, like its EHEC homologues EspF and EspF<sub>U</sub>/Tccp, recruits N-WASP (a key regulator of actin polymerisation), with studies on EspF<sub>U</sub> revealing it specifically activates N-WASP by mimicking an internal regulatory element [<xref rid="bib23 bib24" ref-type="bibr">23,24</xref>]. Finally, although EspF plays an essential role in anti-phagocytosis, EspB–myosin interaction has recently been reported to inhibit both phagocytosis and microvilli effacement [<xref rid="bib25" ref-type="bibr">25<sup>•</sup></xref>]. However, as both of these bacterial processes can occur with EspB/EspF-positive but not EspB-positive/EspF-negative strains [<xref rid="bib19 bib26" ref-type="bibr">19<sup>•</sup>,26</xref>]; this suggests that EspB is neither solely responsible nor sufficient.</p>
      <p>Effector multifunctionality is further demonstrated by Map and Tir which like EspF, possess motifs that mediate a broad array of functions ([<xref rid="bib3" ref-type="bibr">3</xref>]; <xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig2" ref-type="fig">Figure 2</xref>). All of Tir's reported activities depend on its extracellular domain (<xref rid="fig2" ref-type="fig">Figure 2</xref>) binding to Intimin, following Tir insertion into the host plasma membrane. Tir's N-terminal and C-terminal domains remain intracellular and interact with numerous signalling, adapter and cytoskeletal proteins with Tir function dependent on its phosphorylation sites, a GTPase activating protein (GAP)-like motif and a polyproline region (<xref rid="fig2" ref-type="fig">Figure 2</xref>) [<xref rid="bib27 bib28 bib29" ref-type="bibr">27–29</xref>]. Interestingly, although tyrosine phosphorylation of Tir is essential for actin-pedestal formation in immortalised cell lines, human biopsy material has revealed that this crucial event is independent of tyrosine phosphorylation <italic>ex vivo</italic>, suggesting care should be taken when using cell lines to elucidate effector function [<xref rid="bib30" ref-type="bibr">30<sup>••</sup></xref>]. Map on the other hand is reported to mimic the active form of Cdc42 — a small GTPase — to induce filopodia formation [<xref rid="bib31" ref-type="bibr">31</xref>], in contrast to an earlier report demonstrating a dependence on Cdc-42 itself [<xref rid="bib32" ref-type="bibr">32</xref>]. The filopodia-inducing functions of Map depend on an invariant WxxxE motif and a C-terminal class 1 PDZ-binding domain that binds Ezrin-binding protein 50 [<xref rid="bib31 bib33" ref-type="bibr">31,33</xref>] to presumably direct or retain Map to the plasma membrane. Whether or not Map is a Cdc42 mimic is open to debate as other effectors of the WxxxE family appear to require GTPases to elicit their cellular responses [<xref rid="bib32 bib34" ref-type="bibr">32,34<sup>••</sup></xref>] and the controversy surrounding the WxxxE effector family has been eloquently discussed in a recent review which provides a compelling argument to suggest these effectors may not be GTPase mimics after all [<xref rid="bib34" ref-type="bibr">34<sup>••</sup></xref>]. Finally, Map possesses an N-terminal MTS and targets the mitochondria where it is imported via the classical TOM/Hsp70 import system and causes mitochondrial dysfunction [<xref rid="bib35" ref-type="bibr">35</xref>] (see <xref rid="fig1 fig2" ref-type="fig">Figures 1 and 2</xref>).</p>
    </sec>
    <sec>
      <title>EPEC non-LEE effectors and non-LEE pathogenicity islands</title>
      <p>Whilst mining the EHEC (O157:H7 Sakai strain) genome sequence with over 200 known/predicted T3SS-dependent effector proteins, Pallen and colleagues identified 49 putative effectors [<xref rid="bib5" ref-type="bibr">5</xref>]. At least 39 of these predicted proteins, of which many are homologues, were confirmed as secreted effectors in EHEC and include NleA-H (noting 12 NleG homologues) and newly described EspJ-O, EspR and EspV-Y effectors [<xref rid="bib5" ref-type="bibr">5</xref>]. The recent completion of the EPEC genome sequence (strain E2348/69) enabled a similar ‘effector mining’ approach using an expanded list of over 400 known/predicted effector sequences and identified only 21 putative effectors (Dean and Kenny, unpublished; <xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig3" ref-type="fig">Figure 3</xref>). Thus, as recently reported [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>], EPEC appears to have a much smaller non-LEE effector repertoire than EHEC, encoding NleA-H (two homologues of B, E, H and only 1 of NleG), EspJ and EspL2, Orf3 (EspG2; which is the only EPEC effector so far identified that is not present in EHEC) and pseudogenes for NleH, EspO, NleB, EspL and Cif (<xref rid="tbl1" ref-type="table">Table 1</xref> and <xref rid="fig3" ref-type="fig">Figure 3</xref>). Thus, whilst the LEE effector repertoire is well conserved, the set of non-LEE effectors is apparently flexible as EPEC strains B171-8 and E22 (rabbit-EPEC) possess 28 and 40 effectors, respectively, compared to 21 for the prototypical strain [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>].</p>
      <p>The non-LEE effector genes are clustered in six pathogenicity islands (<xref rid="fig3" ref-type="fig">Figure 3</xref>) scattered throughout the genome, usually with a low G + C% content in regions corresponding to effector genes. Interestingly, the non-LEE effector genes are surrounded by phage-related and/or transposase-like genes implying that, like most pathogenicity islands, they were acquired through horizontal acquisition [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>]. Whilst EPEC E2348/69 carries at least 21 effector-encoding genes, it is not known whether they are all expressed but undoubtedly other effectors remain to be identified. Indeed, there are many hypothetical genes in the non-LEE islands that are likely candidates as effectors because of their low %GC content and close proximity to known effector genes (<xref rid="fig3" ref-type="fig">Figure 3</xref>).</p>
      <p>Because of the more recent discovery of non-LEE effectors, relatively little is known about their cellular function (summarised in <xref rid="tbl1" ref-type="table">Table 1</xref>), but NleA is reported to inhibit protein secretion [<xref rid="bib36" ref-type="bibr">36<sup>•</sup></xref>], EspJ inhibits phagocytosis [<xref rid="bib37" ref-type="bibr">37</xref>], whilst NleE [<xref rid="bib38" ref-type="bibr">38</xref>] and NleH [<xref rid="bib39" ref-type="bibr">39</xref>] activate innate immune responses. Studies with the mouse model suggest that EspJ, NleB, NleE, NleF and NleH play a role in colonisation and full virulence [<xref rid="bib40 bib41 bib42 bib43" ref-type="bibr">40–43</xref>] whilst NleC and D have no detectable function [<xref rid="bib40 bib41" ref-type="bibr">40,41</xref>]. Although NleA (also called EspI) was reported to be a key virulence factor [<xref rid="bib44" ref-type="bibr">44</xref>], another study using the same mouse model, reported that it only contributes to full virulence — as with most other effectors [<xref rid="bib10" ref-type="bibr">10</xref>]. Interestingly, despite NleE and NleH reportedly inducing innate immune responses, EPEC T3SS-dependent function has been demonstrated to inhibit, not activate, such responses in small intestinal cells and mouse studies [<xref rid="bib45 bib46" ref-type="bibr">45<sup>•</sup>,46</xref>]. Importantly, the reported inhibitory mechanism was not dependent on LEE effectors, implicating non-LEE effectors in the process [<xref rid="bib45" ref-type="bibr">45<sup>•</sup></xref>] although a LEE effector was recently identified that inhibits NF-κB activation (Kenny <italic>et al.</italic>, unpublished) — revealing yet another overlapping role for LEE and non-LEE effectors. Therefore, a discrepancy exists as NleE and NleH appear to induce inflammatory responses, whilst EPEC's overall effect on host/host cells is anti-inflammatory. It is possible that EPEC transiently induces pro-inflammatory responses but rapidly inactivates this response mechanism before the disruption of TJs, that is associated with onset of inflammatory cascades [<xref rid="bib45" ref-type="bibr">45<sup>•</sup></xref>]. Thus, like the activities of many other EPEC effectors, a delicate balance likely exists between pro-inflammatory and anti-inflammatory signalling mechanisms [<xref rid="bib47" ref-type="bibr">47</xref>].</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>‘Multifunctional, cooperative and redundant’ are three overriding themes that describe EPEC effector behaviour and are becoming increasingly accepted for various T3SS-pathogen effectors. Interestingly, the LEE effectors appear to subvert many ‘core’ epithelial cell processes and consequently, all of the major EPEC disease-related hallmarks have been attributed to the LEE effectors, suggesting the non-LEE effectors may function mainly as accessory/efficiency factors. However, it is worth pointing out that individual non-LEE effectors are more highly conserved between A/E pathogens than LEE effectors [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>], possibly reflecting the targeting of well conserved processes, whilst LEE-effector variability may reflect different host ranges. The high level of functional interdependence between the LEE effectors possibly reflects their continued co-evolution within the LEE pathogenicity island and this sets an exciting precedent that other effectors co-inherited together may display similarly complex levels of interplay. A future challenge will be to define the contribution of all effectors in each disease process by identifying the effector domains and motifs responsible. Only then the contribution of the particular effector function to the disease process can be assessed in animal models. Nonetheless the expanded repertoire of effectors provides fascinating opportunities to understand how pathogens subvert cellular processes and increase our understanding of vital eukaryotic processes.</p>
    </sec>
    <sec>
      <title>References and recommended reading</title>
      <p>Papers of particular interest, published within the period of review, have been highlighted as:<list list-type="simple"><list-item><p>• of special interest</p></list-item><list-item><p>•• of outstanding interest</p></list-item></list></p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgements</title>
      <p>We apologise in advance to the authors of the published work that is not included in this review because of space constraints. Work within our laboratory is funded by the Wellcome Trust.</p>
    </ack>
    <ref-list>
      <title>References</title>
      <ref id="bib1">
        <label>1</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>H.D.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli: unravelling pathogenesis</article-title>
          <source>FEMS Microbiol Rev</source>
          <year>2005</year>
          <volume>29</volume>
          <fpage>83</fpage>
          <lpage>98</lpage>
          <pub-id pub-id-type="pmid">15652977</pub-id>
        </citation>
      </ref>
      <ref id="bib2">
        <label>2</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mundy</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>MacDonald</surname>
              <given-names>T.T.</given-names>
            </name>
            <name>
              <surname>Dougan</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Wiles</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Citrobacter rodentium of mice and man</article-title>
          <source>Cell Microbiol</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>1697</fpage>
          <lpage>1706</lpage>
          <pub-id pub-id-type="pmid">16309456</pub-id>
        </citation>
      </ref>
      <ref id="bib3">
        <label>3</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dean</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Maresca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>EPEC's weapons of mass subversion</article-title>
          <source>Curr Opin Microbiol</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>28</fpage>
          <lpage>34</lpage>
          <pub-id pub-id-type="pmid">15694854</pub-id>
        </citation>
      </ref>
      <ref id="bib4">
        <label>4</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Puente</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Gruenheid</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Vallance</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Barba</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Ibarra</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>O’Donnell</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Metalnikov</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Dissecting virulence: systematic and functional analyses of a pathogenicity island</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2004</year>
          <volume>101</volume>
          <fpage>3597</fpage>
          <lpage>3602</lpage>
          <pub-id pub-id-type="pmid">14988506</pub-id>
        </citation>
      </ref>
      <ref id="bib5">
        <label>5</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tobe</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Beatson</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Taniguchi</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>C.M.</given-names>
            </name>
            <name>
              <surname>Fivian</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Younis</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Matthews</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Marches</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>14941</fpage>
          <lpage>14946</lpage>
          <pub-id pub-id-type="pmid">16990433</pub-id>
        </citation>
      </ref>
      <ref id="bib6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iguchi</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Thomson</surname>
              <given-names>N.R.</given-names>
            </name>
            <name>
              <surname>Ogura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Saunders</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Ooka</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>I.R.</given-names>
            </name>
            <name>
              <surname>Harris</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Asadulghani</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kurokawa</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>The complete genome sequence and comparative genome analysis of enteropathogenic E. coli O127:H6 strain E2348/69</article-title>
          <source>J Bacteriol</source>
          <year>2009</year>
          <volume>191</volume>
          <fpage>347</fpage>
          <lpage>354</lpage>
          <pub-id pub-id-type="pmid">18952797</pub-id>
        </citation>
      </ref>
      <ref id="bib7">
        <label>7</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Spears</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Roe</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Gally</surname>
              <given-names>D.L.</given-names>
            </name>
          </person-group>
          <article-title>A comparison of enteropathogenic and enterohaemorrhagic Escherichia coli pathogenesis</article-title>
          <source>FEMS Microbiol Lett</source>
          <year>2006</year>
          <volume>255</volume>
          <fpage>187</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">16448495</pub-id>
        </citation>
      </ref>
      <ref id="bib8">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vidal</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Navarro-Garcia</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>EspC translocation into epithelial cells by enteropathogenic Escherichia coli requires a concerted participation of type V and III secretion systems</article-title>
          <source>Cell Microbiol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>1975</fpage>
          <lpage>1986</lpage>
          <pub-id pub-id-type="pmid">18547338</pub-id>
        </citation>
      </ref>
      <ref id="bib9">
        <label>9</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Elliott</surname>
              <given-names>S.J.</given-names>
            </name>
            <name>
              <surname>Krejany</surname>
              <given-names>E.O.</given-names>
            </name>
            <name>
              <surname>Mellies</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Robins-Browne</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Sasakawa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Kaper</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>EspG, a novel type III system-secreted protein from enteropathogenic Escherichia coli with similarities to VirA of Shigella flexneri</article-title>
          <source>Infect Immun</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>4027</fpage>
          <lpage>4033</lpage>
          <pub-id pub-id-type="pmid">11349072</pub-id>
        </citation>
      </ref>
      <ref id="bib10">
        <label>10</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mundy</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Petrovska</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Smollett</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Simpson</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Wilson</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Yu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Rosenshine</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Clare</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dougan</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a novel Citrobacter rodentium type III secreted protein, EspI, and roles of this and other secreted proteins in infection</article-title>
          <source>Infect Immun</source>
          <year>2004</year>
          <volume>72</volume>
          <fpage>2288</fpage>
          <lpage>2302</lpage>
          <pub-id pub-id-type="pmid">15039354</pub-id>
        </citation>
      </ref>
      <ref id="bib11">
        <label>11</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marches</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Ledger</surname>
              <given-names>T.N.</given-names>
            </name>
            <name>
              <surname>Boury</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Ohara</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Tu</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Goffaux</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Mainil</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Rosenshine</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Sugai</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>De Rycke</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic and enterohaemorrhagic Escherichia coli deliver a novel effector called Cif, which blocks cell cycle G2/M transition</article-title>
          <source>Mol Microbiol</source>
          <year>2003</year>
          <volume>50</volume>
          <fpage>1553</fpage>
          <lpage>1567</lpage>
          <pub-id pub-id-type="pmid">14651638</pub-id>
        </citation>
      </ref>
      <ref id="bib12">
        <label>12</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanack</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Tatsuno</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Karmali</surname>
              <given-names>M.A.</given-names>
            </name>
            <name>
              <surname>Kaper</surname>
              <given-names>J.B.</given-names>
            </name>
          </person-group>
          <article-title>SepZ/EspZ is secreted and translocated into HeLa cells by the enteropathogenic Escherichia coli type III secretion system</article-title>
          <source>Infect Immun</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>4327</fpage>
          <lpage>4337</lpage>
          <pub-id pub-id-type="pmid">15972527</pub-id>
        </citation>
      </ref>
      <ref id="bib13">
        <label>13</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mills</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Baruch</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Charpentier</surname>
              <given-names>X.</given-names>
            </name>
            <name>
              <surname>Kobi</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Rosenshine</surname>
              <given-names>I.</given-names>
            </name>
          </person-group>
          <article-title>Real-time analysis of effector translocation by the type III secretion system of enteropathogenic Escherichia coli</article-title>
          <source>Cell Host Microbe</source>
          <year>2008</year>
          <volume>3</volume>
          <fpage>104</fpage>
          <lpage>113</lpage>
          <pub-id pub-id-type="pmid">18312845</pub-id>
        </citation>
      </ref>
      <ref id="bib14">
        <label>14</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ma</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Wickham</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Guttman</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Walker</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Madsen</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Jacobson</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Vogl</surname>
              <given-names>W.A.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Vallance</surname>
              <given-names>B.A.</given-names>
            </name>
          </person-group>
          <article-title>Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map)</article-title>
          <source>Cell Microbiol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>1669</fpage>
          <lpage>1686</lpage>
          <pub-id pub-id-type="pmid">16759225</pub-id>
        </citation>
      </ref>
      <ref id="bib15">
        <label>15</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nagai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Abe</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Sasakawa</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Targeting of enteropathogenic Escherichia coli EspF to host mitochondria is essential for bacterial pathogenesis: critical role of the 16th leucine residue in EspF</article-title>
          <source>J Biol Chem</source>
          <year>2005</year>
          <volume>280</volume>
          <fpage>2998</fpage>
          <lpage>3011</lpage>
          <pub-id pub-id-type="pmid">15533930</pub-id>
        </citation>
      </ref>
      <ref id="bib16">
        <label>16</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dean</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Intestinal barrier dysfunction by enteropathogenic Escherichia coli is mediated by two effector molecules and a bacterial surface protein</article-title>
          <source>Mol Microbiol</source>
          <year>2004</year>
          <volume>54</volume>
          <fpage>665</fpage>
          <lpage>675</lpage>
          <pub-id pub-id-type="pmid">15491358</pub-id>
        </citation>
      </ref>
      <ref id="bib17">
        <label>17</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tomson</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Viswanathan</surname>
              <given-names>V.K.</given-names>
            </name>
            <name>
              <surname>Kanack</surname>
              <given-names>K.J.</given-names>
            </name>
            <name>
              <surname>Kanteti</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Straub</surname>
              <given-names>K.V.</given-names>
            </name>
            <name>
              <surname>Menet</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kaper</surname>
              <given-names>J.B.</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli EspG disrupts microtubules and in conjunction with Orf3 enhances perturbation of the tight junction barrier</article-title>
          <source>Mol Microbiol</source>
          <year>2005</year>
          <volume>56</volume>
          <fpage>447</fpage>
          <lpage>464</lpage>
          <pub-id pub-id-type="pmid">15813736</pub-id>
        </citation>
      </ref>
      <ref id="bib18">
        <label>18</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guttman</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Wickham</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Vogl</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Attaching and effacing pathogen-induced tight junction disruption in vivo</article-title>
          <source>Cell Microbiol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>634</fpage>
          <lpage>645</lpage>
          <pub-id pub-id-type="pmid">16548889</pub-id>
        </citation>
      </ref>
      <ref id="bib19">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dean</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Maresca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Schuller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Potent diarrheagenic mechanism mediated by the cooperative action of three enteropathogenic Escherichia coli-injected effector proteins</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>1876</fpage>
          <lpage>1881</lpage>
          <pub-id pub-id-type="pmid">16446436</pub-id>
        </citation>
      </ref>
      <ref id="bib20">
        <label>20</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shaw</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Cleary</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Murphy</surname>
              <given-names>M.S.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Knutton</surname>
              <given-names>S.</given-names>
            </name>
          </person-group>
          <article-title>Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions</article-title>
          <source>Infect Immun</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>1243</fpage>
          <lpage>1251</lpage>
          <pub-id pub-id-type="pmid">15664974</pub-id>
        </citation>
      </ref>
      <ref id="bib21">
        <label>21</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nougayrede</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Donnenberg</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli EspF is targeted to mitochondria and is required to initiate the mitochondrial death pathway</article-title>
          <source>Cell Microbiol</source>
          <year>2004</year>
          <volume>6</volume>
          <fpage>1097</fpage>
          <lpage>1111</lpage>
          <pub-id pub-id-type="pmid">15469437</pub-id>
        </citation>
      </ref>
      <ref id="bib22">
        <label>22</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alto</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Weflen</surname>
              <given-names>A.W.</given-names>
            </name>
            <name>
              <surname>Rardin</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Yarar</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Tonikian</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Koller</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Taylor</surname>
              <given-names>S.S.</given-names>
            </name>
            <name>
              <surname>Boone</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Sidhu</surname>
              <given-names>S.S.</given-names>
            </name>
          </person-group>
          <article-title>The type III effector EspF coordinates membrane trafficking by the spatiotemporal activation of two eukaryotic signaling pathways</article-title>
          <source>J Cell Biol</source>
          <year>2007</year>
          <volume>178</volume>
          <fpage>1265</fpage>
          <lpage>1278</lpage>
          <pub-id pub-id-type="pmid">17893247</pub-id>
        </citation>
      </ref>
      <ref id="bib23">
        <label>23</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cheng</surname>
              <given-names>H.C.</given-names>
            </name>
            <name>
              <surname>Skehan</surname>
              <given-names>B.M.</given-names>
            </name>
            <name>
              <surname>Campellone</surname>
              <given-names>K.G.</given-names>
            </name>
            <name>
              <surname>Leong</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Rosen</surname>
              <given-names>M.K.</given-names>
            </name>
          </person-group>
          <article-title>Structural mechanism of WASP activation by the enterohaemorrhagic E. coli effector EspF(U)</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>454</volume>
          <fpage>1009</fpage>
          <lpage>1013</lpage>
          <pub-id pub-id-type="pmid">18650809</pub-id>
        </citation>
      </ref>
      <ref id="bib24">
        <label>24</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sallee</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Rivera</surname>
              <given-names>G.M.</given-names>
            </name>
            <name>
              <surname>Dueber</surname>
              <given-names>J.E.</given-names>
            </name>
            <name>
              <surname>Vasilescu</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Mullins</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Mayer</surname>
              <given-names>B.J.</given-names>
            </name>
            <name>
              <surname>Lim</surname>
              <given-names>W.A.</given-names>
            </name>
          </person-group>
          <article-title>The pathogen protein EspF(U) hijacks actin polymerization using mimicry and multivalency</article-title>
          <source>Nature</source>
          <year>2008</year>
          <volume>454</volume>
          <fpage>1005</fpage>
          <lpage>1008</lpage>
          <pub-id pub-id-type="pmid">18650806</pub-id>
        </citation>
      </ref>
      <ref id="bib25">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Iizumi</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Sagara</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Kabe</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Azuma</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kume</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Ogawa</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Nagai</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Gillespie</surname>
              <given-names>P.G.</given-names>
            </name>
            <name>
              <surname>Sasakawa</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Handa</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>The enteropathogenic E. coli effector EspB facilitates microvillus effacing and antiphagocytosis by inhibiting myosin function</article-title>
          <source>Cell Host Microbe</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>383</fpage>
          <lpage>392</lpage>
          <pub-id pub-id-type="pmid">18078690</pub-id>
        </citation>
      </ref>
      <ref id="bib26">
        <label>26</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Quitard</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Dean</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Maresca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>The enteropathogenic Escherichia coli EspF effector molecule inhibits PI-3 kinase-mediated uptake independently of mitochondrial targeting</article-title>
          <source>Cell Microbiol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>972</fpage>
          <lpage>981</lpage>
          <pub-id pub-id-type="pmid">16681838</pub-id>
        </citation>
      </ref>
      <ref id="bib27">
        <label>27</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bommarius</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Maxwell</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Swimm</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Leung</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Corbett</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Bornmann</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Kalman</surname>
              <given-names>D.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli Tir is an SH2/3 ligand that recruits and activates tyrosine kinases required for pedestal formation</article-title>
          <source>Mol Microbiol</source>
          <year>2007</year>
          <volume>63</volume>
          <fpage>1748</fpage>
          <lpage>1768</lpage>
          <pub-id pub-id-type="pmid">17367393</pub-id>
        </citation>
      </ref>
      <ref id="bib28">
        <label>28</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hayward</surname>
              <given-names>R.D.</given-names>
            </name>
            <name>
              <surname>Leong</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Koronakis</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Campellone</surname>
              <given-names>K.G.</given-names>
            </name>
          </person-group>
          <article-title>Exploiting pathogenic Escherichia coli to model transmembrane receptor signalling</article-title>
          <source>Nat Rev Microbiol</source>
          <year>2006</year>
          <volume>4</volume>
          <fpage>358</fpage>
          <lpage>370</lpage>
          <pub-id pub-id-type="pmid">16582930</pub-id>
        </citation>
      </ref>
      <ref id="bib29">
        <label>29</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>Attaching effacing Escherichia coli and paradigms of Tir-triggered actin polymerization: getting off the pedestal</article-title>
          <source>Cell Microbiol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>549</fpage>
          <lpage>556</lpage>
          <pub-id pub-id-type="pmid">18053003</pub-id>
        </citation>
      </ref>
      <ref id="bib30">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schuller</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Lewin</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.D.</given-names>
            </name>
          </person-group>
          <article-title>Tir phosphorylation and Nck/N-WASP recruitment by enteropathogenic and enterohaemorrhagic Escherichia coli during ex vivo colonization of human intestinal mucosa is different to cell culture models</article-title>
          <source>Cell Microbiol</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>1352</fpage>
          <lpage>1364</lpage>
          <pub-id pub-id-type="pmid">17474908</pub-id>
        </citation>
      </ref>
      <ref id="bib31">
        <label>31</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Alto</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Shao</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Lazar</surname>
              <given-names>C.S.</given-names>
            </name>
            <name>
              <surname>Brost</surname>
              <given-names>R.L.</given-names>
            </name>
            <name>
              <surname>Chua</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Mattoo</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>McMahon</surname>
              <given-names>S.A.</given-names>
            </name>
            <name>
              <surname>Ghosh</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Hughes</surname>
              <given-names>T.R.</given-names>
            </name>
            <name>
              <surname>Boone</surname>
              <given-names>C.</given-names>
            </name>
          </person-group>
          <article-title>Identification of a bacterial type III effector family with G protein mimicry functions</article-title>
          <source>Cell</source>
          <year>2006</year>
          <volume>124</volume>
          <fpage>133</fpage>
          <lpage>145</lpage>
          <pub-id pub-id-type="pmid">16413487</pub-id>
        </citation>
      </ref>
      <ref id="bib32">
        <label>32</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Ellis</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Leard</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Warawa</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Mellor</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Jepson</surname>
              <given-names>M.A.</given-names>
            </name>
          </person-group>
          <article-title>Co-ordinate regulation of distinct host cell signalling pathways by multifunctional enteropathogenic Escherichia coli effector molecules</article-title>
          <source>Mol Microbiol</source>
          <year>2002</year>
          <volume>44</volume>
          <fpage>1095</fpage>
          <lpage>1107</lpage>
          <pub-id pub-id-type="pmid">12046591</pub-id>
        </citation>
      </ref>
      <ref id="bib33">
        <label>33</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Crepin</surname>
              <given-names>V.F.</given-names>
            </name>
            <name>
              <surname>Mundy</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>FitzGerald</surname>
              <given-names>A.J.</given-names>
            </name>
            <name>
              <surname>Cummings</surname>
              <given-names>N.</given-names>
            </name>
            <name>
              <surname>Straatman-Iwanowska</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Connerton</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Knutton</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The enteropathogenic Escherichia coli type III secretion system effector Map binds EBP50/NHERF1: implication for cell signalling and diarrhoea</article-title>
          <source>Mol Microbiol</source>
          <year>2006</year>
          <volume>60</volume>
          <fpage>349</fpage>
          <lpage>363</lpage>
          <pub-id pub-id-type="pmid">16573685</pub-id>
        </citation>
      </ref>
      <ref id="bib34">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hume</surname>
              <given-names>P.J.</given-names>
            </name>
            <name>
              <surname>Koronakis</surname>
              <given-names>V.</given-names>
            </name>
          </person-group>
          <article-title>Mimicry is the sincerest form of flattery?</article-title>
          <source>Cell Host Microbe</source>
          <year>2008</year>
          <volume>4</volume>
          <fpage>411</fpage>
          <lpage>412</lpage>
          <pub-id pub-id-type="pmid">18996339</pub-id>
        </citation>
      </ref>
      <ref id="bib35">
        <label>35</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Papatheodorou</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Domanska</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Oxle</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Mathieu</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Selchow</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
            <name>
              <surname>Rassow</surname>
              <given-names>J.</given-names>
            </name>
          </person-group>
          <article-title>The enteropathogenic Escherichia coli (EPEC) Map effector is imported into the mitochondrial matrix by the TOM/Hsp70 system and alters organelle morphology</article-title>
          <source>Cell Microbiol</source>
          <year>2006</year>
          <volume>8</volume>
          <fpage>677</fpage>
          <lpage>689</lpage>
          <pub-id pub-id-type="pmid">16548893</pub-id>
        </citation>
      </ref>
      <ref id="bib36">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Thanabalasuriar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Chaworth-Musters</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Fromme</surname>
              <given-names>J.C.</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Lario</surname>
              <given-names>P.I.</given-names>
            </name>
            <name>
              <surname>Metalnikov</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Rizg</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>S.F.</given-names>
            </name>
          </person-group>
          <article-title>The bacterial virulence factor NleA inhibits cellular protein secretion by disrupting mammalian COPII function</article-title>
          <source>Cell Host Microbe</source>
          <year>2007</year>
          <volume>2</volume>
          <fpage>160</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">18005731</pub-id>
        </citation>
      </ref>
      <ref id="bib37">
        <label>37</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marches</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Covarelli</surname>
              <given-names>V.</given-names>
            </name>
            <name>
              <surname>Dahan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Cougoule</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Bhatta</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Caron</surname>
              <given-names>E.</given-names>
            </name>
          </person-group>
          <article-title>EspJ of enteropathogenic and enterohaemorrhagic Escherichia coli inhibits opsono-phagocytosis</article-title>
          <source>Cell Microbiol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>1104</fpage>
          <lpage>1115</lpage>
          <pub-id pub-id-type="pmid">18201246</pub-id>
        </citation>
      </ref>
      <ref id="bib38">
        <label>38</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zurawski</surname>
              <given-names>D.V.</given-names>
            </name>
            <name>
              <surname>Mumy</surname>
              <given-names>K.L.</given-names>
            </name>
            <name>
              <surname>Badea</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Prentice</surname>
              <given-names>J.A.</given-names>
            </name>
            <name>
              <surname>Hartland</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>McCormick</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Maurelli</surname>
              <given-names>A.T.</given-names>
            </name>
          </person-group>
          <article-title>The NleE/OspZ family of effector proteins is required for polymorphonuclear transepithelial migration, a characteristic shared by enteropathogenic Escherichia coli and Shigella flexneri infections</article-title>
          <source>Infect Immun</source>
          <year>2008</year>
          <volume>76</volume>
          <fpage>369</fpage>
          <lpage>379</lpage>
          <pub-id pub-id-type="pmid">17984206</pub-id>
        </citation>
      </ref>
      <ref id="bib39">
        <label>39</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hemrajani</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Marches</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Wiles</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Girard</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Dennis</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Dziva</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Best</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.D.</given-names>
            </name>
            <name>
              <surname>Berger</surname>
              <given-names>C.N.</given-names>
            </name>
            <name>
              <surname>Mousnier</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>Role of NleH, a type III secreted effector from attaching and effacing pathogens, in colonization of the bovine, ovine, and murine gut</article-title>
          <source>Infect Immun</source>
          <year>2008</year>
          <volume>76</volume>
          <fpage>4804</fpage>
          <lpage>4813</lpage>
          <pub-id pub-id-type="pmid">18725419</pub-id>
        </citation>
      </ref>
      <ref id="bib40">
        <label>40</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garcia-Angulo</surname>
              <given-names>V.A.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Puente</surname>
              <given-names>J.L.</given-names>
            </name>
          </person-group>
          <article-title>Regulation of expression and secretion of NleH, a new non-locus of enterocyte effacement-encoded effector in Citrobacter rodentium</article-title>
          <source>J Bacteriol</source>
          <year>2008</year>
          <volume>190</volume>
          <fpage>2388</fpage>
          <lpage>2399</lpage>
          <pub-id pub-id-type="pmid">18223087</pub-id>
        </citation>
      </ref>
      <ref id="bib41">
        <label>41</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kelly</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Hart</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Mundy</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Marches</surname>
              <given-names>O.</given-names>
            </name>
            <name>
              <surname>Wiles</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Badea</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Luck</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tauschek</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Robins-Browne</surname>
              <given-names>R.M.</given-names>
            </name>
          </person-group>
          <article-title>Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium</article-title>
          <source>Infect Immun</source>
          <year>2006</year>
          <volume>74</volume>
          <fpage>2328</fpage>
          <lpage>2337</lpage>
          <pub-id pub-id-type="pmid">16552063</pub-id>
        </citation>
      </ref>
      <ref id="bib42">
        <label>42</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dahan</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Wiles</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>La Ragione</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Best</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Woodward</surname>
              <given-names>M.J.</given-names>
            </name>
            <name>
              <surname>Stevens</surname>
              <given-names>M.P.</given-names>
            </name>
            <name>
              <surname>Shaw</surname>
              <given-names>R.K.</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Knutton</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>A.</given-names>
            </name>
          </person-group>
          <article-title>EspJ is a prophage-carried type III effector protein of attaching and effacing pathogens that modulates infection dynamics</article-title>
          <source>Infect Immun</source>
          <year>2005</year>
          <volume>73</volume>
          <fpage>679</fpage>
          <lpage>686</lpage>
          <pub-id pub-id-type="pmid">15664905</pub-id>
        </citation>
      </ref>
      <ref id="bib43">
        <label>43</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Echtenkamp</surname>
              <given-names>F.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Wickham</surname>
              <given-names>M.E.</given-names>
            </name>
            <name>
              <surname>Vazquez</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Puente</surname>
              <given-names>J.L.</given-names>
            </name>
            <name>
              <surname>Thanabalasuriar</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Gruenheid</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
            <name>
              <surname>Hardwidge</surname>
              <given-names>P.R.</given-names>
            </name>
          </person-group>
          <article-title>Characterization of the NleF effector protein from attaching and effacing bacterial pathogens</article-title>
          <source>FEMS Microbiol Lett</source>
          <year>2008</year>
          <volume>281</volume>
          <fpage>98</fpage>
          <lpage>107</lpage>
          <pub-id pub-id-type="pmid">18279332</pub-id>
        </citation>
      </ref>
      <ref id="bib44">
        <label>44</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gruenheid</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Sekirov</surname>
              <given-names>I.</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>N.A.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>O’Donnell</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>Goode</surname>
              <given-names>D.</given-names>
            </name>
            <name>
              <surname>Li</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Frey</surname>
              <given-names>E.A.</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>N.F.</given-names>
            </name>
            <name>
              <surname>Metalnikov</surname>
              <given-names>P.</given-names>
            </name>
          </person-group>
          <article-title>Identification and characterization of NleA, a non-LEE-encoded type III translocated virulence factor of enterohaemorrhagic Escherichia coli O157:H7</article-title>
          <source>Mol Microbiol</source>
          <year>2004</year>
          <volume>51</volume>
          <fpage>1233</fpage>
          <lpage>1249</lpage>
          <pub-id pub-id-type="pmid">14982621</pub-id>
        </citation>
      </ref>
      <ref id="bib45">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ruchaud-Sparagano</surname>
              <given-names>M.H.</given-names>
            </name>
            <name>
              <surname>Maresca</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Kenny</surname>
              <given-names>B.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function</article-title>
          <source>Cell Microbiol</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>1909</fpage>
          <lpage>1921</lpage>
          <pub-id pub-id-type="pmid">17388785</pub-id>
        </citation>
      </ref>
      <ref id="bib46">
        <label>46</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vallance</surname>
              <given-names>B.A.</given-names>
            </name>
            <name>
              <surname>Deng</surname>
              <given-names>W.</given-names>
            </name>
            <name>
              <surname>Knodler</surname>
              <given-names>L.A.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection</article-title>
          <source>Infect Immun</source>
          <year>2002</year>
          <volume>70</volume>
          <fpage>2070</fpage>
          <lpage>2081</lpage>
          <pub-id pub-id-type="pmid">11895973</pub-id>
        </citation>
      </ref>
      <ref id="bib47">
        <label>47</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sharma</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Tesfay</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tomson</surname>
              <given-names>F.L.</given-names>
            </name>
            <name>
              <surname>Kanteti</surname>
              <given-names>R.P.</given-names>
            </name>
            <name>
              <surname>Viswanathan</surname>
              <given-names>V.K.</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells</article-title>
          <source>Am J Physiol Gastrointest Liver Physiol</source>
          <year>2006</year>
          <volume>290</volume>
          <fpage>G685</fpage>
          <lpage>G694</lpage>
          <pub-id pub-id-type="pmid">16322091</pub-id>
        </citation>
      </ref>
      <ref id="bib48">
        <label>48</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Loukiadis</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Nobe</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Herold</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Tramuta</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Ogura</surname>
              <given-names>Y.</given-names>
            </name>
            <name>
              <surname>Ooka</surname>
              <given-names>T.</given-names>
            </name>
            <name>
              <surname>Morabito</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Kerouredan</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>Brugere</surname>
              <given-names>H.</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>H.</given-names>
            </name>
          </person-group>
          <article-title>Distribution, functional expression, and genetic organization of Cif, a phage-encoded type III-secreted effector from enteropathogenic and enterohemorrhagic Escherichia coli</article-title>
          <source>J Bacteriol</source>
          <year>2008</year>
          <volume>190</volume>
          <fpage>275</fpage>
          <lpage>285</lpage>
          <pub-id pub-id-type="pmid">17873042</pub-id>
        </citation>
      </ref>
      <ref id="bib49">
        <label>49</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hardwidge</surname>
              <given-names>P.R.</given-names>
            </name>
            <name>
              <surname>Donohoe</surname>
              <given-names>S.</given-names>
            </name>
            <name>
              <surname>Aebersold</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Finlay</surname>
              <given-names>B.B.</given-names>
            </name>
          </person-group>
          <article-title>Proteomic analysis of the binding partners to enteropathogenic Escherichia coli virulence proteins expressed in Saccharomyces cerevisiae</article-title>
          <source>Proteomics</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>2174</fpage>
          <lpage>2179</lpage>
          <pub-id pub-id-type="pmid">16552782</pub-id>
        </citation>
      </ref>
      <ref id="bib50">
        <label>50</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lee</surname>
              <given-names>S.F.</given-names>
            </name>
            <name>
              <surname>Kelly</surname>
              <given-names>M.</given-names>
            </name>
            <name>
              <surname>McAlister</surname>
              <given-names>A.</given-names>
            </name>
            <name>
              <surname>Luck</surname>
              <given-names>S.N.</given-names>
            </name>
            <name>
              <surname>Garcia</surname>
              <given-names>E.L.</given-names>
            </name>
            <name>
              <surname>Hall</surname>
              <given-names>R.A.</given-names>
            </name>
            <name>
              <surname>Robins-Browne</surname>
              <given-names>R.M.</given-names>
            </name>
            <name>
              <surname>Frankel</surname>
              <given-names>G.</given-names>
            </name>
            <name>
              <surname>Hartland</surname>
              <given-names>E.L.</given-names>
            </name>
          </person-group>
          <article-title>A C-terminal class I PDZ binding motif of EspI/NleA modulates the virulence of attaching and effacing Escherichia coli and Citrobacter rodentium</article-title>
          <source>Cell Microbiol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>499</fpage>
          <lpage>513</lpage>
          <pub-id pub-id-type="pmid">17979986</pub-id>
        </citation>
      </ref>
      <ref id="bib51">
        <label>51</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nougayrede</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Foster</surname>
              <given-names>G.H.</given-names>
            </name>
            <name>
              <surname>Donnenberg</surname>
              <given-names>M.S.</given-names>
            </name>
          </person-group>
          <article-title>Enteropathogenic Escherichia coli effector EspF interacts with host protein Abcf2</article-title>
          <source>Cell Microbiol</source>
          <year>2007</year>
          <volume>9</volume>
          <fpage>680</fpage>
          <lpage>693</lpage>
          <pub-id pub-id-type="pmid">17064289</pub-id>
        </citation>
      </ref>
      <ref id="bib52">
        <label>52</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Peralta-Ramirez</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>J.M.</given-names>
            </name>
            <name>
              <surname>Manning-Cela</surname>
              <given-names>R.</given-names>
            </name>
            <name>
              <surname>Luna-Munoz</surname>
              <given-names>J.</given-names>
            </name>
            <name>
              <surname>Garcia-Tovar</surname>
              <given-names>C.</given-names>
            </name>
            <name>
              <surname>Nougayrede</surname>
              <given-names>J.P.</given-names>
            </name>
            <name>
              <surname>Oswald</surname>
              <given-names>E.</given-names>
            </name>
            <name>
              <surname>Navarro-Garcia</surname>
              <given-names>F.</given-names>
            </name>
          </person-group>
          <article-title>EspF interacts with nucleation-promoting factors to recruit junctional proteins into pedestals for pedestal maturation and disruption of paracellular permeability</article-title>
          <source>Infect Immun</source>
          <year>2008</year>
          <volume>76</volume>
          <fpage>3854</fpage>
          <lpage>3868</lpage>
          <pub-id pub-id-type="pmid">18559425</pub-id>
        </citation>
      </ref>
      <ref id="bib53">
        <label>53</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hodges</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Alto</surname>
              <given-names>N.M.</given-names>
            </name>
            <name>
              <surname>Ramaswamy</surname>
              <given-names>K.</given-names>
            </name>
            <name>
              <surname>Dudeja</surname>
              <given-names>P.K.</given-names>
            </name>
            <name>
              <surname>Hecht</surname>
              <given-names>G.</given-names>
            </name>
          </person-group>
          <article-title>The enteropathogenic Escherichia coli effector protein EspF decreases sodium hydrogen exchanger 3 activity</article-title>
          <source>Cell Microbiol</source>
          <year>2008</year>
          <volume>10</volume>
          <fpage>1735</fpage>
          <lpage>1745</lpage>
          <pub-id pub-id-type="pmid">18433466</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
  <floats-wrap>
    <fig id="fig1">
      <label>Figure 1</label>
      <caption>
        <p>The complexity of EPEC effector function. The multifunctional and overlapping properties of the EPEC effectors are depicted here by grouping effector functions together. Three effectors have anti-phagocytic activities (shown here using the phagocytic-like gut-associated antigen presenting M-cells) whilst at least five effectors act on microvilli and four inhibit SGLT-1 and other transporter activity, four disrupt tight junctions and three are involved in pedestal and filopodia formation. At least three Nle effectors are also involved in inflammatory pathways. Microtubule and Golgi/ER disruption appears to be specific to EspG/Orf3 and NleA, respectively. Also shown are effectors which have known actin-modulating properties. TJ, tight junctions; MT, microtubules; AqP, aquaporins; NHE3, sodium hydrogen exchanger; Cl/OH, Cl<sup>−</sup>/OH<sup>−</sup> transporter; SGLT-1, sodium glucose cotransporter-1; ER, endoplasmic reticulum; MV, microvilli.</p>
      </caption>
      <graphic xlink:href="gr1"/>
    </fig>
    <fig id="fig2">
      <label>Figure 2</label>
      <caption>
        <p>The modular nature of multifunctional LEE effector proteins. Tir, Map and EspF are the best-studied EPEC effectors and have been implicated in subverting multiple cellular processes. These proteins possess many eukaryotic-like motifs with many being assigned to elicit specific host cellular responses. Only those motifs/domains with proven and documented functions within the host cell are shown whilst chaperone binding sites or the N-terminal bacterial secretion and translocation signals are not shown. Other EPEC effectors are not shown because of the paucity of information regarding their functional domains. See text for abbreviations.</p>
      </caption>
      <graphic xlink:href="gr2"/>
    </fig>
    <fig id="fig3">
      <label>Figure 3</label>
      <caption>
        <p>The six identified non-LEE effector encoding pathogenicity islands of EPEC E2348/69. Predicted effector genes were identified by mining the EPEC genome using over 400 known/predicted effector sequences. The identified effectors and genomic islands support the genome sequence published data (see text), from which the genomic island names were obtained. Only those genomic regions encoding the effectors and with low %GC content (graph above each island) are shown with most prophage-related genes surrounding these regions omitted. Genes and strand direction are shown by individual arrows which are drawn to scale within each island and colour coded (see inset). Multiple copies of genes are numbered according to close homologues in EHEC as explained in the legend to <xref rid="tbl1" ref-type="table">Table 1</xref>. Pseudogene key: (a) Cif; C-terminally truncated protein not produced or secreted in this EPEC strain [<xref rid="bib48" ref-type="bibr">48</xref>]; (b) NleH3; C-terminal truncated; (c) NleO; no start codon; (d) EspL1; stop codon in middle of gene; (e) NleB3; N-terminal truncated.</p>
      </caption>
      <graphic xlink:href="gr3"/>
    </fig>
    <table-wrap position="float" id="tbl1">
      <?landscape?>
      <label>Table 1</label>
      <caption>
        <p>The effector repertoire of EPEC 2348/69 and known functional characteristics of effector proteins.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left">EPEC effector</th>
            <th align="center">Island location</th>
            <th align="center">Cellular/physiological functions</th>
            <th align="center">Subcellular target sites</th>
            <th align="center">Proposed host partners</th>
            <th align="center">Functional motifs</th>
            <th align="center">Homologue family</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left">Tir</td>
            <td align="left">LEE</td>
            <td align="left">Actin polymerisation</td>
            <td align="left">Plasma membrane</td>
            <td align="left">IQGAP1</td>
            <td align="left">SH3-binding domains</td>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">TJ disruption<xref rid="tbl1fn1" ref-type="table-fn">a</xref></td>
            <td align="left">Cytoplasm</td>
            <td align="left">14-3-3tau</td>
            <td align="left">GAP motif</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Cell detachment</td>
            <td/>
            <td align="left">Nck</td>
            <td align="left">Phos. sites</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Microvilli effacement</td>
            <td/>
            <td align="left">α-Actinin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">SGLT-1 inactivation</td>
            <td/>
            <td align="left">Talin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">PLCγ phosphorylation</td>
            <td/>
            <td align="left">Cortactin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Regulating effector activity<xref rid="tbl1fn1" ref-type="table-fn">a</xref></td>
            <td/>
            <td align="left">Vinculin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Invasion non-polarised cells</td>
            <td/>
            <td align="left">Cytokeratin 18</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">Map</td>
            <td align="left">LEE</td>
            <td align="left">TJ disruption</td>
            <td align="left">Mitochondria</td>
            <td align="left">EBP50/</td>
            <td align="left">PDZ1-binding domain</td>
            <td align="left">IpgB2</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Filopodia formation</td>
            <td align="left">Actin<xref rid="tbl1fn1" ref-type="table-fn">a</xref></td>
            <td align="left">NHERF1</td>
            <td align="left">MTS</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Mitochondrial dysfunction</td>
            <td align="left">Cytoplasm</td>
            <td/>
            <td align="left">WxxxE</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Microvilli effacement</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">SGLT-1 inactivation</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Invasion non-polarised cells</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">EspB</td>
            <td align="left">LEE</td>
            <td align="left">Anti-phagocytosis</td>
            <td align="left">Cytoplasm</td>
            <td align="left">Antitrypsin</td>
            <td/>
            <td align="left">YopD</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Microvilli effacement</td>
            <td align="left">Plasma membrane</td>
            <td align="left">α-Catenin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Actin disruption</td>
            <td/>
            <td align="left">Myosin</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Pore formation</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">EspF</td>
            <td align="left">LEE</td>
            <td align="left">Apoptosis</td>
            <td align="left">Mitochondria, cytoplasm</td>
            <td align="left">ABCF2</td>
            <td align="left">PRR,</td>
            <td align="left">None known except other EspF variants such as EspF(U)</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">TJ disruption</td>
            <td align="left">Apical and lateral membranes</td>
            <td align="left">Actin</td>
            <td align="left">SH3</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Microvilli effacement</td>
            <td align="left">TJ region<xref rid="tbl1fn1" ref-type="table-fn">a</xref></td>
            <td align="left">ZO-1/ZO-2</td>
            <td align="left">N-WASP and SNX9 binding domains</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Microvilli elongation</td>
            <td/>
            <td align="left">Profilin</td>
            <td align="left">MTS</td>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">SGLT-1 inactivation</td>
            <td/>
            <td align="left">Arp2/3</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Mitochondrial dysfunction</td>
            <td/>
            <td align="left">Cytokeratin18</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Pedestal maturation</td>
            <td/>
            <td align="left">Sorting nexin 9</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Inhibition of NHE3 activity</td>
            <td/>
            <td align="left">N-WASP</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Membrane remodelling</td>
            <td/>
            <td align="left">14-3-3</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Aquaporin redistribution</td>
            <td/>
            <td align="left">Mito protein<xref rid="tbl1fn2" ref-type="table-fn">b</xref></td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">N-WASP activation</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">EspH</td>
            <td align="left">LEE</td>
            <td align="left">Modulating actin dynamics</td>
            <td align="left">Pedestals</td>
            <td/>
            <td/>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Cytoskeleton disruption</td>
            <td align="left">Plasma membrane</td>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">EspZ</td>
            <td align="left">LEE</td>
            <td align="left">Unknown</td>
            <td align="left">Pedestals</td>
            <td/>
            <td/>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">EspG</td>
            <td align="left">LEE</td>
            <td align="left">Microtubule disruption</td>
            <td align="left">Microtubule colocalisation</td>
            <td align="left">Tubulin</td>
            <td/>
            <td align="left">VirA</td>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">TJ disruption</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Paracellular permeability</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Aquaporin redistribution</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">Stress fibres formation</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td align="left">DRA transporter inhibition</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">NleH1</td>
            <td align="left">PP2</td>
            <td align="left">Pro-inflammatory</td>
            <td/>
            <td/>
            <td/>
            <td align="left">OspG</td>
          </tr>
          <tr>
            <td align="left">EspJ</td>
            <td align="left">PP2</td>
            <td align="left">Anti-phagocytosis</td>
            <td/>
            <td/>
            <td/>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td align="left">NleB2</td>
            <td align="left">PP4</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td align="left">NleC</td>
            <td align="left">PP4</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">AIP56<xref rid="tbl1fn3" ref-type="table-fn">c</xref></td>
          </tr>
          <tr>
            <td align="left">NleD</td>
            <td align="left">PP4</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">HopAP1, HopH1<xref rid="tbl1fn4" ref-type="table-fn">d</xref></td>
          </tr>
          <tr>
            <td align="left">NleG</td>
            <td align="left">PP4</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">None</td>
          </tr>
          <tr>
            <td align="left">NleH2</td>
            <td align="left">PP6</td>
            <td align="left">Pro-inflammatory</td>
            <td/>
            <td/>
            <td/>
            <td align="left">OspG</td>
          </tr>
          <tr>
            <td align="left">NleF</td>
            <td align="left">PP6</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">None</td>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">NleA</td>
            <td align="left">PP6</td>
            <td align="left">Inhibition of protein secretion by interference</td>
            <td align="left">Golgi</td>
            <td align="left">Sec24</td>
            <td align="left">PDZ1</td>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td align="left">(EspI)</td>
            <td/>
            <td align="left">with COPII</td>
            <td/>
            <td align="left">PDZK11</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td/>
            <td align="left">SNX27</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td/>
            <td align="left">MAlS3</td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td/>
            <td/>
            <td/>
            <td/>
            <td align="left">TCOF1<xref rid="tbl1fn2" ref-type="table-fn">b</xref></td>
            <td/>
            <td/>
          </tr>
          <tr>
            <td colspan="7" align="left">  </td>
          </tr>
          <tr>
            <td align="left">NleE2</td>
            <td align="left">IE2</td>
            <td align="left">PMN transepithelial migration</td>
            <td align="left">Nucleus</td>
            <td/>
            <td/>
            <td align="left">OspZ</td>
          </tr>
          <tr>
            <td align="left">EspG2/Orf3</td>
            <td align="left">IE5</td>
            <td align="left">As with EspG</td>
            <td/>
            <td/>
            <td/>
            <td align="left">VirA</td>
          </tr>
          <tr>
            <td align="left">NleB1</td>
            <td align="left">IE6</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">None known</td>
          </tr>
          <tr>
            <td align="left">NleE1</td>
            <td align="left">IE6</td>
            <td align="left">PMN trans-epithelial migration</td>
            <td align="left">Nucleus</td>
            <td/>
            <td/>
            <td align="left">OspZ</td>
          </tr>
          <tr>
            <td align="left">EspL2</td>
            <td align="left">IE6</td>
            <td align="left">Unknown</td>
            <td/>
            <td/>
            <td/>
            <td align="left">OspD<xref rid="tbl1fn5" ref-type="table-fn">e</xref></td>
          </tr>
          <tr>
            <td align="left">EspL1</td>
            <td align="left">IE2</td>
            <td align="left">Pseudogene (see <xref rid="fig3" ref-type="fig">Figure 3</xref>)</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">NleB3</td>
            <td align="left">IE2</td>
            <td align="left">Pseudogene (see <xref rid="fig3" ref-type="fig">Figure 3</xref>)</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">EspO</td>
            <td align="left">PP6</td>
            <td align="left">Pseudogene (see <xref rid="fig3" ref-type="fig">Figure 3</xref>)</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">Cif</td>
            <td align="left">PP2</td>
            <td align="left">Pseudogene (see <xref rid="fig3" ref-type="fig">Figure 3</xref>)</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
          <tr>
            <td align="left">NleH3</td>
            <td align="left">PP4</td>
            <td align="left">Pseudogene (see <xref rid="fig3" ref-type="fig">Figure 3</xref>)</td>
            <td/>
            <td/>
            <td/>
            <td/>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p>The predicted set of EPEC effectors comprises 21 full-length genes and at least 5 identified pseudogenes (i.e. genes truncated by stop codons, missing start codons, containing frameshift mutations). Where more than one copy of an effector exists, genes are numbered in accordance with sequence comparison to known EHEC homologues. For example, the full-length gene EspL is more similar to EHEC EspL2, whilst the EspL pseudogene corresponds with EspL1 and is named accordingly. All effectors are found on the chromosome in pathogenicity islands specified in [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>] and illustrated in <xref rid="fig3" ref-type="fig">Figure 3</xref>. We have attempted to include all the known and documented effector functions and the known subcellular locations from published sources. ‘Homologue family’ gives an example of a known homologue from an effector family; where indicated as ‘none known’ this does not discount similarities with unassigned hypothetical proteins. Island location is illustrated in <xref rid="fig3" ref-type="fig">Figure 3</xref> in accordance with [<xref rid="bib6" ref-type="bibr">6<sup>•</sup></xref>]. All other references can be found in the text or in [<xref rid="bib3" ref-type="bibr">3</xref>]. Phos, phosphorylation; MTS, mitochondrial targeting sequence; PRR, proline-rich repeat; SH3, src homology domains; PMN, polymorphonuclear; TJ, tight junction; IQGAP, IQ motif containing GTPase activating protein; EBP50/NHERF1, Na<sup>+</sup>/H<sup>+</sup> exchanger regulating factor 1; ezrin–radixin–moesin, ERM-binding phosphoprotein of 50 kDa.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tbl1fn1">
          <label>a</label>
          <p>We have attempted to include all the known and documented effector functions and the known subcellular locations from unpublished sources.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tbl1fn2">
          <label>b</label>
          <p>‘Functional motifs’ and ‘proposed host partners’ correspond to those that have been proved to have functional significance, although in some cases, data from yeast two-hybrid protein–protein interactions are included as in [<xref rid="bib49 bib50" ref-type="bibr">49,50</xref>].</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tbl1fn3">
          <label>c</label>
          <p><italic>Photobacterium</italic> virulence protein.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tbl1fn4">
          <label>d</label>
          <p><italic>Pseudomonas syringae</italic> effector proteins.</p>
        </fn>
      </table-wrap-foot>
      <table-wrap-foot>
        <fn id="tbl1fn5">
          <label>e</label>
          <p>Also has <italic>Shiglella</italic> enterotoxin homology.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-wrap>
</article>